Specialty Pharma
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
107
NCT04887506
TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer
Phase: Phase 3
Role: Lead Sponsor
Start: May 5, 2021
Completion: Oct 20, 2022
Loading map...